Chase Knickerbocker
Stock Analyst at Craig-Hallum
(4.94)
# 156
Out of 4,361 analysts
557
Total ratings
56.4%
Success rate
35.2%
Average return
Main Sectors:
Stocks Rated by Chase Knickerbocker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BVS Bioventus | Maintained: Buy | n/a | $8.11 | - | 26 | May 22, 2026 | |
| ETON Eton Pharmaceuticals | Maintained: Buy | n/a | $27.40 | - | 37 | May 20, 2026 | |
| IRWD Ironwood Pharmaceuticals | Maintained: Buy | n/a | $3.28 | - | 32 | May 13, 2026 | |
| XTNT Xtant Medical Holdings | Maintained: Buy | n/a | $0.465 | - | 37 | May 13, 2026 | |
| HROW Harrow | Maintained: Buy | n/a | $32.86 | - | 43 | May 11, 2026 | |
| PYPD PolyPid | Maintained: Buy | n/a | $4.87 | - | 18 | May 11, 2026 | |
| ACOG Alpha Cognition | Maintained: Buy | n/a | $6.18 | - | 2 | May 11, 2026 | |
| NRXS NeurAxis | Maintained: Buy | n/a | $7.01 | - | 12 | May 11, 2026 | |
| XERS Xeris Biopharma Holdings | Reiterated: Buy | $12 | $6.00 | +100.00% | 26 | May 8, 2026 | |
| KRMD KORU Medical Systems | Maintained: Buy | n/a | $4.05 | - | 27 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $5.43 | - | 26 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $189 | $91.42 | +106.74% | 26 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 → $6 | $3.57 | +68.07% | 41 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $9.65 | - | 32 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.58 | - | 19 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $2.50 | +60.00% | 17 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $10.53 | - | 27 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $13.76 | - | 33 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $13.76 | - | 15 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $5.77 | - | 22 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $1.1 | $1.06 | +3.77% | 16 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $72.34 | - | 1 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $166.63 | - | 1 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $88.76 | - | 1 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $73.47 | - | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $232.89 | - | 3 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $114.22 | - | 2 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.6515 | - | 1 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $113.00 | - | 1 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $8.55 | - | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15.92 | $13.00 | n/a | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.27 | n/a | 1 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $41.91 | n/a | 1 | Aug 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 | $17.79 | n/a | 1 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $21.35 | n/a | 1 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $2.62 | n/a | 1 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $5.73 | n/a | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $3.07 | n/a | 1 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $20.77 | n/a | 1 | Aug 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $8.88 | n/a | 1 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $58 | $36.58 | n/a | 1 | May 3, 2023 |
Bioventus
May 22, 2026
Maintained: Buy
Price Target: n/a
Current: $8.11
Upside: -
Eton Pharmaceuticals
May 20, 2026
Maintained: Buy
Price Target: n/a
Current: $27.40
Upside: -
Ironwood Pharmaceuticals
May 13, 2026
Maintained: Buy
Price Target: n/a
Current: $3.28
Upside: -
Xtant Medical Holdings
May 13, 2026
Maintained: Buy
Price Target: n/a
Current: $0.465
Upside: -
Harrow
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $32.86
Upside: -
PolyPid
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $4.87
Upside: -
Alpha Cognition
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $6.18
Upside: -
NeurAxis
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $7.01
Upside: -
Xeris Biopharma Holdings
May 8, 2026
Reiterated: Buy
Price Target: $12
Current: $6.00
Upside: +100.00%
KORU Medical Systems
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $4.05
Upside: -
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $5.43
Upside: -
May 4, 2026
Reiterated: Buy
Price Target: $189
Current: $91.42
Upside: +106.74%
Apr 30, 2026
Rated: Buy
Price Target: $7 → $6
Current: $3.57
Upside: +68.07%
Apr 28, 2026
Maintained: Buy
Price Target: n/a
Current: $9.65
Upside: -
Apr 28, 2026
Maintained: Buy
Price Target: n/a
Current: $4.58
Upside: -
Apr 24, 2026
Reiterated: Buy
Price Target: $4
Current: $2.50
Upside: +60.00%
Apr 22, 2026
Maintained: Buy
Price Target: n/a
Current: $10.53
Upside: -
Apr 22, 2026
Maintained: Buy
Price Target: n/a
Current: $13.76
Upside: -
Apr 6, 2026
Maintained: Buy
Price Target: n/a
Current: $13.76
Upside: -
Mar 30, 2026
Maintained: Buy
Price Target: n/a
Current: $5.77
Upside: -
Mar 10, 2026
Rated: Buy
Price Target: $1.1
Current: $1.06
Upside: +3.77%
Nov 20, 2025
Maintained: Buy
Price Target: n/a
Current: $72.34
Upside: -
Nov 19, 2025
Maintained: Buy
Price Target: n/a
Current: $166.63
Upside: -
Oct 20, 2025
Maintained: Buy
Price Target: n/a
Current: $88.76
Upside: -
Oct 17, 2025
Rated: Hold
Price Target: n/a
Current: $73.47
Upside: -
Oct 9, 2025
Maintained: Buy
Price Target: n/a
Current: $232.89
Upside: -
Oct 8, 2025
Maintained: Buy
Price Target: n/a
Current: $114.22
Upside: -
Jul 23, 2025
Rated: Hold
Price Target: n/a
Current: $0.6515
Upside: -
Jul 22, 2025
Maintained: Buy
Price Target: n/a
Current: $113.00
Upside: -
Jul 14, 2025
Maintained: Buy
Price Target: n/a
Current: $8.55
Upside: -
Feb 26, 2025
Maintained: Buy
Price Target: $15.92
Current: $13.00
Upside: n/a
Feb 5, 2025
Maintained: Buy
Price Target: n/a
Current: $4.27
Upside: n/a
Aug 28, 2024
Rated: Buy
Price Target: n/a
Current: $41.91
Upside: n/a
Aug 1, 2024
Maintained: Buy
Price Target: $38
Current: $17.79
Upside: n/a
Jul 18, 2024
Initiated Coverage: Buy
Price Target: n/a
Current: $21.35
Upside: n/a
Mar 21, 2024
Maintained: Buy
Price Target: $10
Current: $2.62
Upside: n/a
Oct 16, 2023
Rated: Buy
Price Target: n/a
Current: $5.73
Upside: n/a
Sep 13, 2023
Rated: Buy
Price Target: n/a
Current: $3.07
Upside: n/a
Aug 18, 2023
Rated: Buy
Price Target: n/a
Current: $20.77
Upside: n/a
May 4, 2023
Rated: Buy
Price Target: n/a
Current: $8.88
Upside: n/a
May 3, 2023
Rated: Buy
Price Target: $58
Current: $36.58
Upside: n/a